Funding awarded
- Patterns of HIV archival drug resistance in intact versus defective proviral DNA genomes awarded by Merck & Co., Inc. Principal Investigator 2025 - 2026
- Characterization of Non-subtype B HIV-1 Reservoirs and its Association with Longitudinal Clinical Outcomes awarded by National Institute of Allergy & Infectious Diseases Principal Investigator 2021 - 2026
- REACH: Research Enterprise to Advance a Cure for HIV awarded by National Institute of Allergy & Infectious Diseases Co-Principal Investigator 2021 - 2026
- Impact of Neonatal ART and Broadly Neutralizing Antibodies on HIV-1 Reservoirs in Infants: Towards ART-free Remission awarded by National Institute of Neurological Disorders & Stroke Principal Investigator Subaward 2024 - 2029
- missing activity Principal Investigator Subaward 2023 - 2024
- missing activity Principal Investigator Subaward 2023 - 2024